Akram Wisam, Nori Wassan, Abdul Ghani Zghair Muna
Department of Obstetrics and Gynecology, Mustansiriyah, Al Saydihya 10052, Baghdad, Iraq.
Department of Radiology, Mustansiriyah, Al Saydihya 10052, Baghdad, Iraq.
World J Clin Cases. 2023 Feb 26;11(6):1318-1329. doi: 10.12998/wjcc.v11.i6.1318.
Insulin resistance (IR) was reported in most polycystic ovarian syndrome (PCOS) cases. Metformin, a biguanide drug, successfully reduced IR. Homeostatic Model Assessment for IR (HOMA-IR) and Doppler parameters assessed metformin's effectiveness.
To verify whether the area under the curve of the internal carotid artery (AUC-ICA) Doppler wave can be a useful marker for assessing IR among PCOS cases who presented with menstrual irregularity and were treated with metformin over 6 mo.
An observational, cross-sectional study recruited 54 eligible PCOS women; the anthropometrics were as follows: age, body mass index (BMI), menstrual cycle days, biochemical serum cholesterol, low and high-density lipoprotein, sex hormone-binding globulin, fasting blood glucose, and HOMA-IR, hormonal testosterone, luteinizing hormone over follicle-stimulating hormone ratio, and ultrasonic pulsatility index (PI) and resistance index (RI), carotid artery intima-media thickness (CIMT) and (AUC-ICA) parameters were initially recorded and repeated 3 mo and 6 mo later with metformin tab 500 mg; three times/day for 6 mo. In addition, AUC-ICA was assessed by taking repeated systolic and diastolic wave height measurements.
Metformin caused a progressive reduction in BMI, menstrual cycle days, biochemical hormonal, and Doppler parameters (CIMT, PI, RI, and AUC-ICA). AUC-ICA correlated strongly to all PCOS parameters. AUC-ICA correlated inversely with treatment time ( = -0.98, 0.001) and positively with HOMA-IR ( = 0.98, 0.0001). the best subset regression model, the AUC-ICA had the highest predictive value for HOMA-IR.
AUC-ICA preceded PI, RI, and CIMT with a strong, meaningful correlation to all PCOS parameters, making it a reliable marker for the assessment of IR, especially during metformin therapy. Further studies are recommended to promote the application in practice.
大多数多囊卵巢综合征(PCOS)病例中都存在胰岛素抵抗(IR)。二甲双胍作为一种双胍类药物,能有效降低IR。稳态模型评估胰岛素抵抗(HOMA-IR)和多普勒参数可用于评估二甲双胍的疗效。
验证颈内动脉(AUC-ICA)多普勒波曲线下面积能否作为评估月经不规律且接受二甲双胍治疗6个月以上的PCOS患者IR的有效指标。
一项观察性横断面研究纳入了54例符合条件的PCOS女性;测量的人体测量学指标如下:年龄、体重指数(BMI)、月经周期天数、生化血清胆固醇、低密度和高密度脂蛋白、性激素结合球蛋白、空腹血糖和HOMA-IR、激素睾酮、黄体生成素与促卵泡激素比值,以及超声搏动指数(PI)和阻力指数(RI),最初记录颈动脉内膜中层厚度(CIMT)和(AUC-ICA)参数,3个月和6个月后重复测量,同时服用500mg二甲双胍片,每日3次,共6个月。此外,通过重复测量收缩波和舒张波高度来评估AUC-ICA。
二甲双胍使BMI、月经周期天数、生化激素和多普勒参数(CIMT、PI、RI和AUC-ICA)逐渐降低。AUC-ICA与所有PCOS参数密切相关。AUC-ICA与治疗时间呈负相关(r = -0.98,P < 0.001),与HOMA-IR呈正相关(r = 0.98,P < 0.0001)。在最佳子集回归模型中,AUC-ICA对HOMA-IR的预测价值最高。
AUC-ICA在PI、RI和CIMT之前出现,与所有PCOS参数具有强烈且有意义的相关性,使其成为评估IR的可靠指标,尤其是在二甲双胍治疗期间。建议进一步开展研究以促进其在实际中的应用。